Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)

Inclusion Criteria: * Clinically documented angioedema due to C1 inhibitor deficiency, hereditary (type I et II) or acquired * Clinically documented angioedema with normal C1 inhibitor activity (hereditary type III) Exclusion Criteria: * Acquired angioedema with normal C1 inhibitor activity (former "drug-induced") * Minor subjects * Vulnerable subjects (under guardianship/curatorship/tutorship) * Pregnant women